1. Home
  2. LKFN vs IMCR Comparison

LKFN vs IMCR Comparison

Compare LKFN & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Financial Corporation

LKFN

Lakeland Financial Corporation

HOLD

Current Price

$59.29

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$36.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKFN
IMCR
Founded
1872
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
LKFN
IMCR
Price
$59.29
$36.52
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$67.00
$67.00
AVG Volume (30 Days)
143.2K
333.0K
Earning Date
01-23-2026
11-06-2025
Dividend Yield
3.34%
N/A
EPS Growth
N/A
N/A
EPS
3.79
N/A
Revenue
$248,271,000.00
$379,590,000.00
Revenue This Year
$17.16
$32.31
Revenue Next Year
$3.98
$10.50
P/E Ratio
$15.79
N/A
Revenue Growth
2.85
28.11
52 Week Low
$50.00
$23.15
52 Week High
$75.19
$40.72

Technical Indicators

Market Signals
Indicator
LKFN
IMCR
Relative Strength Index (RSI) 54.41 49.05
Support Level $57.98 $35.35
Resistance Level $60.56 $40.71
Average True Range (ATR) 1.45 1.82
MACD 0.26 -0.45
Stochastic Oscillator 70.89 22.55

Price Performance

Historical Comparison
LKFN
IMCR

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: